Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 21, 2024
Displaying entries 38001 - 38050 of 39437 in total
PDB ID UniProt ID Title ▼ Descriptor
5V8L Q2N0S6 BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145 gp120, gp41, 3BNC117 antibody, heavy chain, PGT145 antibody, heavy chain, 3BNC117 antibody, light chain, PGT145 antibody, light chain
5V8L 5V8L BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145 gp120, gp41, 3BNC117 antibody, heavy chain, PGT145 antibody, heavy chain, 3BNC117 antibody, light chain, PGT145 antibody, light chain
7KDE Q2N0S6 BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 interface antibody 8ANC195 HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein gp120, Ab 1485 Heavy Chain, Ab 1485 Light Chain, 8ANC195 Fab Heavy Chain, 8ANC195 Fab Light Chain
7KDE 7KDE BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 interface antibody 8ANC195 HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein gp120, Ab 1485 Heavy Chain, Ab 1485 Light Chain, 8ANC195 Fab Heavy Chain, 8ANC195 Fab Light Chain
5VIY Q2N0S6 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY P01834 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY 5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY P01834 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY 5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY S6B291 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY S6B291 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY Q8TCD0 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY Q8TCD0 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
6V0R Q2N0S6 BG505 SOSIP.664 Trimer BG505 SOSIPv5.2 gp120, BG505 SOSIPv5.2 gp41
6VL5 6VL5 BG505 SOSIP reconstructed from a designed tetrahedral nanoparticle, BG505 SOSIP-T33_dn2 BG505 SOSIP.v5.2(7S) - gp120, BG505 SOSIP.v5.2(7S) - gp41
7L7U 7L7U BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component B)
7L7T 7L7T BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component A)
6CM3 Q2N0S7 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6CM3 Q2N0S5 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6CM3 P01730 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6CM3 6CM3 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
7L8D 7L8D BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.33104 (Wk26 time point)
7L89 7L89 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.32034 (Wk26 time point)
7L8C 7L8C BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.33104 (Wk26 time point)
7L88 7L88 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.32034 (Wk26 time point)
7L8B 7L8B BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.33104 (Wk26 time point)
7L87 7L87 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.32034 (Wk26 time point)
7L8A 7L8A BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.33104 (Wk26 time point)
7L86 7L86 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.32034 (Wk26 time point)
7MDU Q2N0S6 BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3
7MDU 7MDU BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3
6NFC 6NFC BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP42 fragmentantigen binding and base-binding RM20A3 fragment antigen binding base-binding RM20A3 fragment antigen binding heavy chain, base-binding RM20A3 fragment antigen binding light chain, HIV-1 Env BG505 MD64 N332-GT5 SOSIP gp120, HIV-1 Env BG505 MD64 N332-GT5 SOSIP gp41, BG18-like precursor HMP42 fragment antigen binding heavy chain, BG18-like precursor HMP42 fragment antigen binding light chain
6NF5 6NF5 BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP1 fragmentantigen binding and base-binding RM20A3 fragment antigen binding HIV-1 Env BG505 MD64 N332-GT5 SOSIP gp120, HIV-1 Env BG505 MD64 N332-GT5 SOSIP gp41, BG18-like precursor HMP1 fragment antigen binding heavy chain, V2-17 protein, base-binding RM20A3 fragment antigen binding heavy chain, base-binding RM20A3 fragment antigen binding light chain
6DFH Q2N0S6 BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain
6DFH Q2N0S5 BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain
6DFH 6DFH BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain
6DFG Q2N0S6 BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain
6DFG Q2N0S8 BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain
6DFG 6DFG BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain
8SW4 8SW4 BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3
8SW4 Q2N0S6 BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3
8T2F 8T2F BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
8SWW 8SWW BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
8SWV 8SWV BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
8T2E 8T2E BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
8SW7 8SW7 BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
8SWX 8SWX BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
1C7T Q54468 BETA-N-ACETYLHEXOSAMINIDASE MUTANT E540D COMPLEXED WITH DI-N ACETYL-D-GLUCOSAMINE (CHITOBIASE)
1C7S Q54468 BETA-N-ACETYLHEXOSAMINIDASE MUTANT D539A COMPLEXED WITH DI-N-ACETYL-BETA-D-GLUCOSAMINE (CHITOBIASE)
1CF5 P29339 BETA-MOMORCHARIN STRUCTURE AT 2.55 A
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback
International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024